Hong Luo

Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low Breast Cancer.

Jin-xiu Shi, Hong Ling, Bo-yue Han, 2024, Cancer letters.

Integrated Multi-Omics Profiling of Young Breast Cancer Patients Reveals a Correlation between Galactose Metabolism Pathway and Poor Disease-Free Survival

Hong Ling, Bo-yue Han, Hong Luo, 2023, Cancers.